[go: up one dir, main page]

WO2018222164A3 - Use of an herbal formula containing pumpkin seed oil in bph treatment - Google Patents

Use of an herbal formula containing pumpkin seed oil in bph treatment Download PDF

Info

Publication number
WO2018222164A3
WO2018222164A3 PCT/TR2018/050068 TR2018050068W WO2018222164A3 WO 2018222164 A3 WO2018222164 A3 WO 2018222164A3 TR 2018050068 W TR2018050068 W TR 2018050068W WO 2018222164 A3 WO2018222164 A3 WO 2018222164A3
Authority
WO
WIPO (PCT)
Prior art keywords
seed oil
pumpkin seed
formula containing
herbal formula
bph treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050068
Other languages
French (fr)
Other versions
WO2018222164A9 (en
WO2018222164A2 (en
Inventor
Mevlüt Büyükhelvacigi̇l
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Original Assignee
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS filed Critical Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Publication of WO2018222164A2 publication Critical patent/WO2018222164A2/en
Publication of WO2018222164A3 publication Critical patent/WO2018222164A3/en
Publication of WO2018222164A9 publication Critical patent/WO2018222164A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Dans l'industrie pharmaceutique, la présente invention concerne l'utilisation d'une préparation à base d'herbes sous la forme d'une capsule molle ayant des propriétés antioxydantes, préparée avec de l'huile de pépins de courge particulièrement riche en acides gras essentiels, dans le traitement de la HBP (hyperplasie bénigne de la prostate). Ladite préparation à base d'herbes comprend de l'huile de pépins de courge, du dl-α-tocophérol, du dl-α-tocophéryl acétate, de la glycérine, de l'eau distillée et de la gélatine maintenant l'intégrité du contenu et de la forme de la capsule.In the pharmaceutical industry, the present invention relates to the use of a herbal preparation in the form of a soft capsule having antioxidant properties, prepared with pumpkin seed oil particularly rich in fatty acids. essential for the treatment of BPH (benign prostatic hyperplasia). Said herbal preparation comprises pumpkin seed oil, dl-α-tocopherol, dl-α-tocopheryl acetate, glycerin, distilled water and gelatin maintaining the integrity of the content and shape of the capsule.

PCT/TR2018/050068 2017-02-28 2018-02-26 Use of an herbal formula containing pumpkin seed oil in bph treatment Ceased WO2018222164A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/03079 2017-02-28
TR2017/03079A TR201703079A2 (en) 2017-02-28 2017-02-28 THE USE OF A VEGETABLE FORMULATION CONTAINING PUMPKIN SEED OIL IN THE TREATMENT OF BPH

Publications (3)

Publication Number Publication Date
WO2018222164A2 WO2018222164A2 (en) 2018-12-06
WO2018222164A3 true WO2018222164A3 (en) 2019-04-04
WO2018222164A9 WO2018222164A9 (en) 2019-05-02

Family

ID=64455729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050068 Ceased WO2018222164A2 (en) 2017-02-28 2018-02-26 Use of an herbal formula containing pumpkin seed oil in bph treatment

Country Status (2)

Country Link
TR (1) TR201703079A2 (en)
WO (1) WO2018222164A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109528806B (en) * 2018-12-19 2021-08-06 刘东波 Sterol composition in pumpkin seed oil and its application and medicine for treating benign prostatic hyperplasia

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000290192A (en) * 1999-04-05 2000-10-17 Hide Tatsuzaki Therapeutic agent for dysuria
US20080031940A1 (en) * 2006-08-02 2008-02-07 Al Rodriguez Quercetin-containing composition, methods of making, and methods of using
WO2009004039A2 (en) * 2007-07-04 2009-01-08 Glaxosmithkline Consumer Healthcare Gmbh & Co. Kg Formulation
WO2012029199A1 (en) * 2010-08-28 2012-03-08 アサマ化成株式会社 Tea bag containing cucurbit seeds
CN104189695A (en) * 2014-09-17 2014-12-10 兰成然 Chinese herbal medicine preparation for treating uroclepsia and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000290192A (en) * 1999-04-05 2000-10-17 Hide Tatsuzaki Therapeutic agent for dysuria
US20080031940A1 (en) * 2006-08-02 2008-02-07 Al Rodriguez Quercetin-containing composition, methods of making, and methods of using
WO2009004039A2 (en) * 2007-07-04 2009-01-08 Glaxosmithkline Consumer Healthcare Gmbh & Co. Kg Formulation
WO2012029199A1 (en) * 2010-08-28 2012-03-08 アサマ化成株式会社 Tea bag containing cucurbit seeds
CN104189695A (en) * 2014-09-17 2014-12-10 兰成然 Chinese herbal medicine preparation for treating uroclepsia and preparation method thereof

Also Published As

Publication number Publication date
WO2018222164A9 (en) 2019-05-02
WO2018222164A2 (en) 2018-12-06
TR201703079A2 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
Da Silva et al. Isolation and characterization of ellagic acid derivatives isolated from Casearia sylvestris SW aqueous extract with anti-PLA2 activity
Joung et al. Anti-inflammatory action of the ethanolic extract from Sargassum serratifolium on lipopolysaccharide-stimulated mouse peritoneal macrophages and identification of active components
Hanuš Pharmacological and therapeutic secrets of plant and brain (endo) cannabinoids
Xia et al. Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential Oil
De Cicco et al. Chamomile essential oils exert anti-inflammatory effects involving human and murine macrophages: Evidence to support a therapeutic action
Benso et al. Anti-inflammatory, anti-osteoclastogenic and antioxidant effects of Malva sylvestris extract and fractions: in vitro and in vivo studies
Carone et al. A new l-amino acid oxidase from Bothrops jararacussu snake venom: Isolation, partial characterization, and assessment of pro-apoptotic and antiprotozoal activities
Silva et al. Untangling the bioactive properties of therapeutic deep eutectic solvents based on natural terpenes
Deng et al. Analgesic and anti-inflammatory bioactivities of eburicoic acid and dehydroeburicoic acid isolated from Antrodia camphorata on the inflammatory mediator expression in mice
Shreadah et al. Phytochemical and pharmacological screening of Sargassium vulgare from Suez Canal, Egypt
Metibemu et al. Carotenoid isolates of Spondias mombin demonstrate anticancer effects in DMBA‐induced breast cancer in Wistar rats through X‐linked inhibitor of apoptosis protein (XIAP) antagonism and anti‐inflammation
EA200501285A1 (en) METHOD OF OBTAINING LIPOSOMAL DRUGS
Kim et al. Free radical scavenging activity of the peptide from the Alcalase hydrolysate of the edible aquacultural seahorse (Hippocampus abdominalis)
Pang et al. Physicochemical properties, antioxidant activities and protective effect against acute ethanol-induced hepatic injury in mice of foxtail millet (Setaria italica) bran oil
Guo et al. Unravelling oncosis: morphological and molecular insights into a unique cell death pathway
Urda et al. Daedophamide, a cytotoxic cyclodepsipeptide from a Daedalopelta sp. sponge collected in Indonesia
Baothman et al. Phytochemical analysis and nephroprotective potential of Ajwa date in doxorubicin‐induced nephrotoxicity rats: Biochemical and molecular docking approaches
Hosseinymehr et al. 8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity
WO2018222164A3 (en) Use of an herbal formula containing pumpkin seed oil in bph treatment
Lam et al. Latex C‐serum from H evea brasiliensis induces non‐apoptotic cell death in hepatocellular carcinoma cell line (HepG2)
Sang et al. Polysaccharides from Hemerocallis citrina Baroni inhibit the growth of hepatocellular carcinoma cells by regulating the wnt/β-catenin pathway
Savoia et al. Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes
Helmy et al. Increment of lysosomal biogenesis by combined extracts of gum arabic, parsley, and corn silk: A reparative mechanism in mice renal cells
WO2018222163A3 (en) Use of an herbal formula containing pumpkin seed oil in the treatment of overactive bladder and urinary incontinence of the lower urinary system symptoms
Hamaidia et al. From Valeriana officinalis to cancer therapy: the success of a bio-sourced compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18810778

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18810778

Country of ref document: EP

Kind code of ref document: A2